Litigation Details for TRIS PHARMA, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2020)
✉ Email this page to a colleague
TRIS PHARMA, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2020)
Docket | ⤷ Sign Up | Date Filed | 2020-04-28 |
Court | District Court, D. New Jersey | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | |
Jury Demand | Referred To | ||
Patents | 6,419,960; 8,999,386; 9,545,399; 9,844,544 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in TRIS PHARMA, INC. v. TEVA PHARMACEUTICALS USA, INC.
Details for TRIS PHARMA, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2022-08-16 | 206 | Opinion | • U.S. Patent No. 4,996,047 (“Kelleher”) (JTX-059) • U.S. Patent No. 6,419,960 (“Krishnamurthy…of five patents: United States Patent No. 9,545,399 (“the ’399 patent”), United States Patent No. 9,844,544…the ’544 patent”), United States Patent No. 9,844,545 (“the ’545 patent”), United States Patent No. 11,103,494…,494 (“the ’494 patent”), and United States Patent No. 11,103,495 (“the ’495 patent”) (collectively,…the ’399 patent; claim 37 of the ’544 patent; claims 17, 23, 24, and 28 of the ’545 patent; claim 28 | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |